Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial

Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has removed a citation regarding the safety, efficacy, and tolerability of efgartigimod in patients with generalized myasthenia gravis, which is a significant study in the field.
    Difference
    0.4%
    Check dated 2025-05-07T22:28:04.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T19:51:28.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed trial descriptions and eligibility criteria for the ARGX-113 study, while a new revision number has been added.
    Difference
    14%
    Check dated 2025-04-16T13:26:51.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:56:14.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:49:39.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:27:22.000Z thumbnail image

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.